Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap

INTRODUCTION: Cell count in induced sputum is a noninvasive biomarker to assess airway inflammation phenotypes. Accordingly, sputum cell counts are extensively used in the treatment of asthma and COPD. Nevertheless, the clinical application of sputum cell counts in patients with asthma–COPD overlap...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jie, Zhou, Wutie, Chen, Bida, Lin, Weiming, Wu, Sifang, Wu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602440/
https://www.ncbi.nlm.nih.gov/pubmed/28979112
http://dx.doi.org/10.2147/COPD.S142466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602440/
https://www.ncbi.nlm.nih.gov/pubmed/28979112
http://dx.doi.org/10.2147/COPD.S142466

Ejemplares similares